- Home
- EP vs ZNTL Comparison
EP vs ZNTL Comparison
Compare EP & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- ZNTL
- Stock Information
- Founded
- EP 1983
- ZNTL 2014
- Country
- EP United States
- ZNTL United States
- Employees
- EP N/A
- ZNTL N/A
- Industry
- EP Oil & Gas Production
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- EP Energy
- ZNTL Health Care
- Exchange
- EP Nasdaq
- ZNTL Nasdaq
- Market Cap
- EP 109.9M
- ZNTL 118.3M
- IPO Year
- EP N/A
- ZNTL 2020
- Fundamental
- Price
- EP $3.19
- ZNTL $1.28
- Analyst Decision
- EP
- ZNTL Buy
- Analyst Count
- EP 0
- ZNTL 6
- Target Price
- EP N/A
- ZNTL $6.53
- AVG Volume (30 Days)
- EP 40.9K
- ZNTL 783.4K
- Earning Date
- EP 11-13-2025
- ZNTL 11-06-2025
- Dividend Yield
- EP N/A
- ZNTL N/A
- EPS Growth
- EP N/A
- ZNTL N/A
- EPS
- EP N/A
- ZNTL N/A
- Revenue
- EP $39,170,178.00
- ZNTL $26,865,000.00
- Revenue This Year
- EP N/A
- ZNTL N/A
- Revenue Next Year
- EP N/A
- ZNTL N/A
- P/E Ratio
- EP N/A
- ZNTL N/A
- Revenue Growth
- EP N/A
- ZNTL N/A
- 52 Week Low
- EP $2.80
- ZNTL $1.01
- 52 Week High
- EP $8.12
- ZNTL $4.44
- Technical
- Relative Strength Index (RSI)
- EP 38.06
- ZNTL 33.22
- Support Level
- EP $2.80
- ZNTL $1.49
- Resistance Level
- EP $4.08
- ZNTL $1.54
- Average True Range (ATR)
- EP 0.27
- ZNTL 0.10
- MACD
- EP -0.01
- ZNTL -0.04
- Stochastic Oscillator
- EP 31.25
- ZNTL 11.24
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the United States onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.